Skip to main content
. 2024 Jan 5;13(1):113–126. doi: 10.1007/s40122-023-00570-6

Table 2.

Analysis of primary and secondary outcome measures

Outcome measures Parameter Value p value (description)
Primary outcome measures  Pain

Pre-treatment score

Post-treatment score

Difference

2684 patients (7.56 ± 1.80)

2672 patients (4.43 ± 2.14)

2672 patients (3.12 ± 1.96)

0.0008* (difference)
 Function/ADL

Yes

No

2492 patients (96.36%)

94 patients (3.64%)

 < 0.0001*
 Medication usage

Eliminated

Decreased

No effect

231 patients (11%)

1123 patients (53.42%)

748 patients (35.58%)

 < 0.0001* (eliminated + decreased vs. no effect)
 Sleep improvement

Yes

No

1620 patients (59.76%)

1091 patients (40.24%)

 < 0.0001*
Secondary outcome measures  Work performance

Yes

No

830 patients (81.61%)

187 patients (18.39%)

 < 0.0001*
 Preference for HWDS compared to prior treatment

More

Same

Less

1658 patients (63.40%)

905 patients (34.60%)

52 patients (2.00%)

 < 0.0001* (HWDS vs. prior treatments)
 Patient expectation

Exceeded

Met

Fallen short

863 patients (33.43%)

1604 patients (62.12%)

115 patients (4.45%)

 < 0.0001* (exceeded or met vs. falling short)
 Patient satisfaction with service

Excellent

Satisfactory

Poor

2208 patients (84.11%)

405 patients (15.43%)

12 patients (0.46%)

 < 0.0001* (excellent or satisfactory vs. poor)
 Patient confidence in device use

Excellent

Satisfactory

Poor

1980 patients (75.60%)

621 patients (23.71%)

18 patients (0.69%)

 < 0.0001* (excellent or satisfactory vs. poor)

*Demonstrates statistical significance